Stem cells repair damaged retinas in aging eyes

The retina is part of the central nervous system. Like the brain, it relies on a protective barrier: the inner blood-retina barrier (iBRB). This barrier controls which molecules pass from the bloodstream into retinal tissue. When it breaks down and leaks, oxygen delivery and cell health are disrupted. That is precisely what happens in conditions such as diabetic retinopathy and macular degeneration, two common causes of blindness in older adults.

Building cells from pluripotent stem cells

The researchers took induced pluripotent stem cells (iPSCs), which are body cells reprogrammed back to an early, versatile state, and directed them to become retinal endothelial cells. Endothelial cells line the interior walls of blood vessels. In the retina, they join tightly to form the barrier. The conversion was achieved via activation of the Wnt-beta-catenin signalling pathway, a well-known regulator of cell identity.

The newly produced cells (iRECs) displayed the correct genetic and molecular characteristics of genuine retinal endothelial cells. They were then injected into mice with oxygen-induced retinopathy, a standard mouse model for retinal injury. The cells integrated into the existing vascular network and contributed to restoring blood flow in damaged tissue.

Still a long way to the clinic

These are early, promising results in an animal model. Whether the approach is safe and effective in humans remains to be established. Risks such as immune rejection or unwanted cell growth need to be ruled out. That said, the method holds potential for a wide range of conditions in which the retinal barrier plays a role, including age-related eye diseases.

From a longevity standpoint, this is worth noting: retinal aging follows mechanisms similar to brain aging. Therapies that restore vascular barriers could therefore have broader relevance beyond eye disease alone, though this study does not demonstrate that directly.

Read the original article